Additional file 1: Table S1. of Aboriginal and non-Aboriginal children in Western Australia carry different serotypes of pneumococci with different antimicrobial susceptibility profiles

7vPCV vaccination characteristics of the study participants. Table S2. Prevalences of pneumococcal serotypes found in the respiratory tract of study participants 1999–2005. Table S3. Reduced antimicrobial susceptibility of Streptococcus pneumoniae in nasopharyngeal samples from Aboriginal children reported by serotype. Table S4. Reduced antimicrobial susceptibility of Streptococcus pneumoniae in nasopharyngeal samples from non-Aboriginal children reported by serotype. Table S5. The molecular type by pulse-field gel electrophoresis (PFGE) of 199 S. pneumoniae isolates reported by serotype. (DOCX 26 kb

Proportion of serotypeable pneumococci isolated from the nasopharynx between 2008 and 2011 that are included in 7vPCV, 13vPCV, 23vPPV, or no currently licensed vaccine, by age group.

<p>A 7vPCV program was introduced in 2001 for all Aboriginal children. Specimens were collected prior to introduction of 13vPCV in July 2011.</p

Distribution of the 12 most common pneumococcal serotypes by age group.

<p>Distribution of the 12 most common pneumococcal serotypes by age group.</p

Prevalence of <i>S. pneumoniae</i> carriage in 1500 Aboriginal people (<5 years, ≥ 5 years) by Western Australian health regions.

<p>N = number of nasopharyngeal swabs collected per region for participants (< 5 years, ≥ 5 years). Overall, the prevalence of <i>S</i>. <i>pneumoniae</i> carriage was 71.9% in children < 5 years, and 34.6% in people ≥ 5 years. Specimens were collected 1 Aug 2008 - 30 June 2011.</p